Pura Vida Investments, LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Pura Vida Investments, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 12, 2021	SELL	$72.25 - $168.95 $2.89 Million - $6.76 Million	-40,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $11.6 Million - $16.5 Million	-92,400 Reduced 69.79%	40,000 $6.82 Million
Q2 2020 Feb 12, 2021	BUY	$93.0 - $171.7 $12.2 Million - $22.5 Million	131,076 Added 9900.0%	132,400 $21.2 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $11.9 Million - $22 Million	-128,076 Reduced 98.98%	1,324 $937,000
Q1 2020 Feb 12, 2021	BUY	$82.38 - $131.64 $10.6 Million - $16.9 Million	128,106 Added 9900.0%	129,400 $12.7 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $8.87 Million - $14.2 Million	-107,706 Reduced 98.81%	1,294 $3.85 Million
Q4 2019 Feb 12, 2021	BUY	$76.53 - $135.58 $8.26 Million - $14.6 Million	107,910 Added 9900.0%	109,000 $14.1 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $7.57 Million - $13.4 Million	-98,910 Reduced 98.91%	1,090 $2.15 Million
Q3 2019 Feb 12, 2021	BUY	$72.81 - $156.91 $7.21 Million - $15.5 Million	99,000 Added 9900.0%	100,000 $7.53 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $72,810 - $156,910	1,000 New	1,000 $4.42 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.